Oncology Video

3rd China-US Anti-Cancer Summit 2023

Oncologists discuss trial data and treatment approaches from both countries: On-demand webinar

Prof. Daiming Fan

Prof. Daiming Fan
Prof. Philip Greenberg

Prof. Philip Greenberg
Prof. Lynn M. Schuchter

Prof. Lynn M. Schuchter
Prof. William L. Dahut

Prof. William L. Dahut
Prof. Caicun Zhou

Prof. Caicun Zhou
Prof. Rui-Hua Xu

Prof. Rui-Hua Xu
Prof. Ying Wang

Prof. Ying Wang
Prof. Li Yan

Prof. Li Yan
Publication Date

Dec 2023

download Downloadable resources

In December 2023, cancer specialists from China and the US came together to attend the virtual 3rd China-US Anti-Cancer Summit, co-organised by the China Anti-Cancer Association (CACA) and the US-China Anti-Cancer Association (USCACA).

 

Anti-cancer leaders from China and the US took part in presentations and a panel discussion and exchanged ideas and perspectives on the following:

  • The development of holistic, integrative management of cancer in China
  • Cancer research progress in the US
  • Innovations in oncology: the role of ASCO in improving cancer care
  • Treatment of advanced lung cancer: current and future perspectives

 

The panel of experts also discussed how to collaborate internationally to ensure global relevance of locally generated trial data and to harmonise regulations for trial endpoints to strengthen the global fight against cancer.

 

Educational objectives

 

  • Share insights and perspectives on the management and treatment of cancer patients in the US and China
  • Inform oncologists about the current and future developments in lung cancer 
  • Generate awareness of the latest innovations and progress in cancer research in the US and China

Programme summary
  • clock Duration 150 MIN
  • clock Language(s) flag
Watch the video now
Share this programme
x-twitter
This educational programme is supported by an Independent Educational Grant from BeiGene Europe, AmoyDx and Fosun Pharma.
Supporter Acknowledgement
This educational programme is supported by an Independent Educational Grant from BeiGene Europe, AmoyDx and Fosun Pharma.
Endorsement
Echinahealth
I agree that this educational programme:

Was valuable to me

1/4

Other programmes of interest

micro-learning Micro learning

Module

4

of 4

module
Oncology 
Navigating advanced HCC: treatment strategies beyond immunotherapy (IO)

Module 4: Treatment strategies for patients ineligible for IO or those with progression on IO 

Experts
Assoc. Prof. Lorenza Rimassa, Dr Amit Singal
Endorsed by
DiCE ELPA Global Liver Institute
Blue Faery AASLD
  • download Downloadable
    Resources
  • clock 3 MIN
  • calendar Jun 2025
HCC CONNECT GI CONNECT Non-accredited Independent Medical Education
Educational programme supported by an Independent Educational Grant from Bayer.
conference-update Conference update
Oncology 
Highlights from ASCO 2025

Expert insights on the latest data 

Experts
Prof. Mark Socinski, Dr Elizabeth Smyth, Dr Paolo Tarantino, Prof. Domenica Lorusso, Prof. Gerhardt Attard
Endorsed by
Exon20group Biomarker Collaborative ICAN international cancer advocacy network
Lung Cancer Europe
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Jun 2025
COR2ED Non-accredited Independent Medical Education
The oncogene-addicted NSCLC supported through an Independent Educational Grant from Bayer with all other updates supported by COR2ED
conference-update Conference update
Oncology 
Highlights from ASCO 2025: BRAF-mutant and MSI-H/dMMR colorectal cancer (CRC)

Expert opinion on the latest practice-changing data

Experts
Prof. Dominik Modest, Dr Sara Lonardi
  • clock 5 MIN
  • calendar Jun 2025
GI CONNECT GI NURSES CONNECT PRECISION ONCOLOGY CONNECT Non-accredited Independent Medical Education
This content is intended for HCPs outside the UK & ROI only. The medical experts in this video are expressing their own views and not those of COR2ED, Supporters or their institution. This programme is supported by an Independent Educational Grant from Pierre Fabre Laboratories.  The programme is, therefore, independent; the content is not influenced by Pierre Fabre Laboratories and is under the sole responsibility of the experts.
symposium Symposium
Oncology 
ER+/HER2- metastatic breast cancer: Highlights from ESMO Breast Cancer 2025 Satellite Symposium

Medical experts discuss treatment strategies and sequencing after ET + CDK4/6i for ER+/HER2- metastatic breast cancer

Experts
Prof. Wolfgang Janni, Prof. Sherko Kümmel, Prof. Michail Ignatiadis
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar May 2025
COR2ED
This programme has been sponsored by Menarini Stemline and is intended for healthcare professionals only
podcast Podcast
Hemostasis and bleeding disorders Oncology 
Serie de podcasturi referitoare la gestionarea trombozei

Experți de renume din domeniul medical își împărtășesc perspectivele. Navigați în secțiuni pentru a selecta un episod al podcastului 

Experts
Prof. Dimitrios Tsakiris, Dr Lars Asmis, Prof. Jerzy Windyga, Prof. Daniel Bolliger
  • download Downloadable
    Resources
  • clock 21 MIN
  • calendar May 2025
COR2ED Non-accredited Independent Medical Education
This educational programme is supported by an Independent Educational Grant from Viatris.
video Video
Oncology Hemato-oncology 
Optimising the sequence of novel therapies from early relapse in multiple myeloma

Improving the survival of patients with relapsed/refractory multiple myeloma

Experts
Prof. Hermann Einsele, Prof. Evangelos Terpos
  • download Downloadable
    Resources
  • clock 2 MIN
  • calendar May 2025
COR2ED
This programme has been sponsored by Menarini Stemline and is intended for healthcare professionals only
Explore all programmes